OTC Syringe Sales to Prevent HIV in Underserved Areas of Inland California
销售非处方药注射器以预防加利福尼亚州内陆服务欠缺地区的艾滋病毒
基本信息
- 批准号:8466903
- 负责人:
- 金额:$ 65.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-01-01 至 2016-12-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAccountingAddressAgricultureAreaCaliforniaCanadaCharacteristicsCitiesCocaineCommunitiesComplementCountyDataEnvironmentEpidemicGeographic LocationsHIVHIV InfectionsHIV riskHeroinIndividualInjecting drug userInjection of therapeutic agentInternationalInterviewKnowledgeLatinoLaw EnforcementLawsMethamphetamineMethodsMexicanMexicoModelingNatural experimentNeedle SharingNeedle-Exchange ProgramsPharmaceutical PreparationsPharmacy facilityPhasePlayPopulationPrevention ResearchPrevention strategyPreventive InterventionProductionResearchRisk BehaviorsRoleRouteRuralSalesStatutes and LawsSterilitySurveysSyringesUnited Statesbasedesigndrug marketexperienceinformantinjection drug useinnovationmetropolitanmultidisciplinarypreventprogramspublic health relevancesocialsuccesstooltraffickingtransmission processuptakeurban area
项目摘要
DESCRIPTION (provided by applicant): This study will capitalize on the opportunity for a "natural experiment" in HIV prevention to assess the implementation of a new syringe access law, Senate Bill 41 (SB41), in the inland counties of California's Central Valley. Injection drug use rates in the Central Valley's southern counties are among the highest in the U.S. and contribute substantially to the region's HIV epidemic. SB41, which went into effect on January 1, 2012, allows pharmacies to sell up to 30 syringes without a prescription. Although the law has the potential to greatly expand syringe access in inland California's predominantly rural and Latino counties, which have thus far been greatly underserved by other syringe access programs, syringe sales under the law are voluntary and it is unclear to what extent pharmacies will participate. Our study will use an innovative mixed methods approach to (1) assess pharmacy implementation of this new over-the counter (OTC) syringe law, (2) characterize utilization of OTC syringe sales by injection drug users (IDUs) under the law, and 3) examine structural factors associated with both pharmacy implementation and IDU utilization. The study will be conducted in two counties, Fresno and Kern, using a three-phase approach to address factors at all three levels of the HIV "risk environment." In Phase I, we will conduct a syringe purchase trial (N=298), a brief pharmacy survey (N=596), and key informant interviews (N=32) to assess pharmacies' implementation of the law and characterize related barriers and facilitators. In Phase II, we will conduct an IDU survey (N=550) to understand IDU uptake of OTC syringe purchase under the law and identify related barriers and facilitators. In Phase III, we will conduct geospatial/contextual modeling to complement findings from Phases I & II and elucidate structural factors that influence SB41's impact. At the conclusion of our study, we will have generated a comprehensive understanding of the factors that facilitate and impede SB41's success as an HIV prevention tool. This information will assist the communities of inland California in developing multi-level strategies to optimize OTC syringe sales, reduce syringe sharing, and prevent HIV transmission among IDUs.
描述(由申请人提供):本研究将利用艾滋病毒预防“自然实验”的机会,评估加州中央谷内陆县实施新的注射器获取法,参议院法案41(SB 41)。中央谷南部各县的注射毒品使用率是美国最高的,是该地区艾滋病毒流行的主要原因。SB 41于2012年1月1日生效,允许药店在没有处方的情况下出售多达30支注射器。尽管该法律有可能大大扩大加州内陆主要是农村和拉丁裔县的注射器获取,但到目前为止,其他注射器获取计划的服务严重不足,但根据该法律的注射器销售是自愿的,目前还不清楚药店将在多大程度上参与。我们的研究将使用创新的混合方法来(1)评估药房实施这项新的非处方(OTC)注射器法,(2)根据法律规定,描述注射药物使用者(IDUs)使用OTC注射器销售的特征,以及3)检查与药房实施和IDU使用相关的结构因素。这项研究将在弗雷斯诺和克恩两个县进行,采用三阶段方法来解决艾滋病毒风险环境所有三个层次的因素。“在第一阶段,我们将进行注射器购买试验(N=298),简短的药房调查(N=596)和关键线人访谈(N=32),以评估药房对法律的执行情况,并描述相关的障碍和促进因素。在第二阶段,我们将进行一项IDU调查(N=550),以了解IDU根据法律购买OTC注射器的情况,并确定相关的障碍和促进因素。在第三阶段,我们将进行地理空间/背景建模,以补充第一阶段和第二阶段的发现,并阐明影响SB 41影响的结构因素。在我们的研究结束时,我们将全面了解促进和阻碍SB 41作为艾滋病毒预防工具取得成功的因素。这些信息将帮助内陆加州社区制定多层次的战略,以优化OTC注射器销售,减少注射器共享,并防止注射吸毒者之间的艾滋病毒传播。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robin A Pollini其他文献
Robin A Pollini的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robin A Pollini', 18)}}的其他基金
Identifying Stigma Reduction Targets in the Context of an Appalachian HIV Outbreak
在阿巴拉契亚艾滋病毒爆发的背景下确定减少耻辱的目标
- 批准号:
10415554 - 财政年份:2022
- 资助金额:
$ 65.39万 - 项目类别:
Identifying Stigma Reduction Targets in the Context of an Appalachian HIV Outbreak
在阿巴拉契亚艾滋病毒爆发的背景下确定减少耻辱的目标
- 批准号:
10670313 - 财政年份:2022
- 资助金额:
$ 65.39万 - 项目类别:
Pharmacy Naloxone Distribution: Assessing a New Tool to Reduce Overdose Mortality
药房纳洛酮分布:评估降低用药过量死亡率的新工具
- 批准号:
9629678 - 财政年份:2017
- 资助金额:
$ 65.39万 - 项目类别:
Pharmacy Naloxone Distribution: Assessing a New Tool to Reduce Overdose Mortality
药房纳洛酮分布:评估降低用药过量死亡率的新工具
- 批准号:
10092988 - 财政年份:2017
- 资助金额:
$ 65.39万 - 项目类别:
Pharmacy Naloxone Distribution: Assessing a New Tool to Reduce Overdose Mortality
药房纳洛酮分布:评估降低用药过量死亡率的新工具
- 批准号:
9113804 - 财政年份:2016
- 资助金额:
$ 65.39万 - 项目类别:
OTC Syringe Sales to Prevent HIV in Underserved Areas of Inland California
销售非处方药注射器以预防加利福尼亚州内陆服务欠缺地区的艾滋病毒
- 批准号:
8780622 - 财政年份:2013
- 资助金额:
$ 65.39万 - 项目类别:
OTC Syringe Sales to Prevent HIV in Underserved Areas of Inland California
销售非处方药注射器以预防加利福尼亚州内陆服务欠缺地区的艾滋病毒
- 批准号:
8601068 - 财政年份:2013
- 资助金额:
$ 65.39万 - 项目类别:
Defining the Role of Mexican Pharmacies in HIV Prevention-A Mixed Method Approach
定义墨西哥药房在艾滋病毒预防中的作用——混合方法
- 批准号:
8283008 - 财政年份:2007
- 资助金额:
$ 65.39万 - 项目类别:
Defining the Role of Mexican Pharmacies in HIV Prevention-A Mixed Method Approach
定义墨西哥药房在艾滋病毒预防中的作用——混合方法
- 批准号:
7497029 - 财政年份:2007
- 资助金额:
$ 65.39万 - 项目类别:
Defining the Role of Mexican Pharmacies in HIV Prevention-A Mixed Method Approach
定义墨西哥药房在艾滋病毒预防中的作用——混合方法
- 批准号:
7908794 - 财政年份:2007
- 资助金额:
$ 65.39万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 65.39万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 65.39万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 65.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 65.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 65.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 65.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 65.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 65.39万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 65.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 65.39万 - 项目类别: